Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 192
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03077776 | Tracking Triple-negative Breast Cancer Evolution Through Therapy | ||
| NCT06653777 | Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells | ||
| NCT02845999 | Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab | ||
| NCT04163887 | Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases | ||
| NCT02907372 | Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer | ||
| NCT04437381 | Molecular Targets for the Treatment of Histiocytosis | ||
| NCT05048771 | Fertility and Temporality in Pediatric Oncology | ||
| NCT02789384 | CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. | ||
| NCT06503393 | SENOVIE France - Therapeutic Mobility and Breast Cancer | ||
| NCT01105364 | Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer | ||
| NCT03759626 | I2S-Health Prevention | ||
| NCT03915678 | Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors | ||
| NCT00435851 | Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients | ||
| NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT02540174 | Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment | ||
| NCT04007640 | Early Screening of Pancreatic Lesions : Development of New Imaging Tools | ||
| NCT01165346 | Stereotaxic Irradiation of Hepatocellular Carcinoma | ||
| NCT01251666 | Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening | ||
| NCT03519048 | Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma | ||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors | ||
| NCT03518606 | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours | ||
| NCT06575452 | Using the Epitranscriptome to Diagnose and Treat Gliomas | ||
| NCT02364206 | Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma | ||
| NCT02438761 | PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK) | ||
| NCT02526095 | The French EsoGastricTumours Data Base | ||
| NCT01540058 | Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP | ||
| NCT00433706 | Image Guided Radiation Therapy For Prostate Cancer | ||
| NCT01112254 | Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer | ||
| NCT03212742 | Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients | ||
| NCT06781996 | A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer | ||
| NCT06749847 | HPV Self-sampling in the General Population | ||
| NCT02689622 | PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes. | ||
| NCT01331772 | Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy | ||
| NCT02648100 | Basal Like Bladder Cancer : Signature and Therapeutic | ||
| NCT03569488 | Validation of the French Version of the Low Anterior Resection Syndrome (LARS) Among Rectal Cancer Patients | ||
| NCT05754892 | Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE) | ||
| NCT01737450 | Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive | ||
| NCT04222335 | Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients | ||
| NCT05456074 | Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR) | ||
| NCT01466868 | Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT07241273 | SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer | ||
| NCT02305056 | Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC) | ||
| NCT01596816 | Hypofractionated Stereotactic Boost in Prostate Cancer | ||
| NCT06939322 | LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) | ||
| NCT02730611 | Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma | ||
| NCT05333432 | Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer | ||
| NCT01287923 | Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans | ||
| NCT02606149 | Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life | ||
| NCT02029001 | Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment | ||
| NCT02304809 | Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations |
